Search results
Results from the WOW.Com Content Network
Hemolytic–uremic syndrome (HUS) is a group of blood disorders characterized by low red blood cells, acute kidney injury (previously called acute renal failure), and low platelets. [ 1 ] [ 3 ] Initial symptoms typically include bloody diarrhea , fever , vomiting , and weakness.
Hemolytic–Uremic Syndrome Triad: Anaemia, Thrombocytopenia, Kidney failure (But see Pentad of TTP below) Hemolytic–uremic syndrome: Horner's Syndrome Triad: ptosis (eyelid), miosis, anhydrosis: Horner's syndrome: Hutchinson's triad: Hutchison's teeth, Interstitial keratitis, Nerve deafness: Congenital syphilis: Kartagener Syndrome Triad
Bacterial toxins are the primary cause of one category of thrombotic microangiopathy known as HUS or hemolytic uremic syndrome. HUS can be divided into two main categories: Shiga-toxin-associated HUS (STx-HUS), which normally presents with diarrhea, and atypical HUS. The Shiga-toxin inhibits the binding of eEF-1-dependent binding of aminoacyl ...
In extreme cases, E. coli may lead to a type of kidney failure called hemolytic uremic syndrome (HUS), ... What the symptoms are: Lethargy, nausea, vomiting, loss of appetite, joint pain and dark ...
Symptoms of E. coli, depending on the strain, (E. coli) according to the CDC include: ... The CDC says some people may develop serious kidney problems called hemolytic uremic syndrome or HUS, a ...
The O157:H7 strain can also cause a very dangerous complication called hemolytic uremic syndrome (HUS), which involves damage to the blood vessels, leading to red blood cell destruction and kidney ...
This characteristic is shared by two related syndromes, hemolytic-uremic syndrome (HUS) and atypical hemolytic uremic syndrome (aHUS). [4] Consequently, differential diagnosis of these TMA diseases is essential. Both TTP and HUS are characterized by fever, anemia, thrombocytopenia, renal failure, and neurological symptoms. Generally, TTP has ...
Atypical hemolytic uremic syndrome (aHUS), also known as complement-mediated hemolytic uremic syndrome (not to be confused with hemolytic–uremic syndrome), is an extremely rare, life-threatening, progressive disease that frequently has a genetic component. In most cases, it can be effectively controlled by interruption of the complement cascade.